Cargando…

The impact of nutritional status in nivolumab-treated patients with advanced esophageal cancer

Although phase III trials have reported improved overall survival in patients with advanced esophageal squamous cell carcinoma following treatment with nivolumab, as compared with chemotherapy (paclitaxel or docetaxel), the treatment was effective only in a limited number of patients. Therefore, the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takegawa, Naoki, Hirabayashi, Taku, Tanaka, Shunta, Nishikawa, Michiko, Tokuyama, Nagahiro, Mimura, Takuya, Kushida, Saeko, Tsumura, Hidetaka, Yamamoto, Yoshinobu, Miki, Ikuya, Tsuda, Masahiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10162549/ https://www.ncbi.nlm.nih.gov/pubmed/37146004 http://dx.doi.org/10.1371/journal.pone.0285365

Ejemplares similares

Pretreatment Glasgow prognostic score as a predictor of outcomes in nivolumab-treated patients with advanced gastric cancer
por: Tokuyama, Nagahiro, et al.
Publicado: (2021)

Assessment of photodynamic therapy as a salvage treatment for local failure after chemoradiotherapy or radiotherapy for esophageal cancer in patients aged 80 years or older
por: Nishikawa, Michiko, et al.
Publicado: (2022)

Clinical Factors of Delayed Perforation after Endoscopic Submucosal Dissection for Gastric Neoplasms
por: Yamamoto, Yoshinobu, et al.
Publicado: (2017)

Nivolumab‐induced sialadenitis
por: Takahashi, Saeko, et al.
Publicado: (2018)

Intractable hiccups caused by esophageal diverticular candidiasis in an immunocompetent adult: a case report
por: Yahata, Shinsuke, et al.
Publicado: (2017)

Severe Esophagitis and Gastritis from Nivolumab Therapy
por: Boike, Justin, et al.
Publicado: (2017)

Nivolumab in combination with radiotherapy for metastatic esophageal neuroendocrine carcinoma after esophagectomy: a case report
por: Takagi, Kuniyasu, et al.
Publicado: (2021)

Profile of Nivolumab in the Treatment of Resected Esophageal Squamous Cell Carcinoma: A Review of the Clinical Data
por: Kim, Yuntae, et al.
Publicado: (2023)

Transition of the PD-1 occupancy of nivolumab on T cells after discontinuation and response of nivolumab re-challenge
por: Nose, Taku, et al.
Publicado: (2022)

Can we do without chemotherapy? A perspective on the combinations nivolumab-chemotherapy and nivolumab–ipilimumab in metastatic gastric and esophageal cancer
por: Derks, Sarah, et al.
Publicado: (2022)

Nivolumab induced hyperprogressive disease in advanced esophageal squamous cell carcinoma
por: Sun, Dantong, et al.
Publicado: (2020)

Rheumatoid Arthritis Symptoms Diagnosed by Rheumatic Immune-related Adverse Events Caused by Nivolumab in a Patient with Esophageal Cancer
por: Yasui, Sho, et al.
Publicado: (2022)

Case series of pleomorphic carcinomas of the lung treated with nivolumab
por: Kanazu, Masaki, et al.
Publicado: (2017)

Nivolumab-induced immune thrombocytopenia in a patient with malignant pleural mesothelioma
por: Sakakibara-Konishi, Jun, et al.
Publicado: (2020)

Colonic Perforation After Treatment With Nivolumab in Esophageal Cancer: A Case Report
por: Cho, Hye Jung, et al.
Publicado: (2021)

Nivolumab-Induced Colitis in a Patient With Esophageal Adenocarcinoma: A Case Report
por: Vlachos, Iakovos, et al.
Publicado: (2023)

Patients With Antithyroid Antibodies Are Prone To Develop Destructive Thyroiditis by Nivolumab: A Prospective Study
por: Kobayashi, Tomoko, et al.
Publicado: (2018)

Post-event Processing Predicts Impaired Cortisol Recovery Following Social Stressor: The Moderating Role of Social Anxiety
por: Maeda, Shunta, et al.
Publicado: (2017)

A case of pleural effusion caused by Mycobacterium fortuitum and Mycobacterium mageritense coinfection
por: Hirabayashi, Ryosuke, et al.
Publicado: (2019)

A severe case of refractory esophageal stenosis induced by nivolumab and responding to tocilizumab therapy
por: Horisberger, Alice, et al.
Publicado: (2018)

Long‐term efficacy and predictive correlates of response to nivolumab in Japanese patients with esophageal cancer
por: Kato, Ken, et al.
Publicado: (2020)

Nivolumab-Induced Severe Akathisia in an Advanced Lung Cancer Patient
por: Abe, Jiro, et al.
Publicado: (2016)

Nivolumab versus chemotherapy in Japanese patients with advanced esophageal squamous cell carcinoma: a subgroup analysis of a multicenter, randomized, open-label, phase 3 trial (ATTRACTION-3)
por: Takahashi, Masanobu, et al.
Publicado: (2020)

Lung Adenocarcinoma with Lynch Syndrome and the Response to Nivolumab
por: Kawashima, Yosuke, et al.
Publicado: (2019)

Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab
por: Boku, Narikazu, et al.
Publicado: (2021)

Prognostic Markers in Head and Neck Cancer Patients Treated with Nivolumab
por: Nishikawa, Daisuke, et al.
Publicado: (2018)

A Randomized Comparison of Nivolumab versus Nivolumab + Docetaxel for Previously Treated Advanced or Recurrent ICI-Naïve Non–Small Cell Lung Cancer: TORG1630
por: Taniguchi, Yuri, et al.
Publicado: (2022)

Endoplasmic Reticulum–Mitochondria Contact Sites—Emerging Intracellular Signaling Hubs
por: Aoyama-Ishiwatari, Saeko, et al.
Publicado: (2021)

Acute Interstitial Nephritis With Karyomegalic Epithelial Cells After Nivolumab Treatment—Two Case Reports
por: Ryuzaki, Masaki, et al.
Publicado: (2019)

Clinical evaluation of palliative chemoradiotherapy for metastatic esophageal cancer
por: Ueda, Hiroto, et al.
Publicado: (2017)

Large cell neuroendocrine carcinoma of the lung that responded to nivolumab: A case report
por: Takimoto Sato, Michiko, et al.
Publicado: (2020)

A Patient with Nivolumab-related Fulminant Type 1 Diabetes Mellitus whose Serum C-peptide Level Was Preserved at the Initial Detection of Hyperglycemia
por: Yamamoto, Naoko, et al.
Publicado: (2019)

Modeling SARS-CoV-2 infection and its individual differences with ACE2-expressing human iPS cells
por: Sano, Emi, et al.
Publicado: (2021)

Regulation of mating type switching by the mating type genes and RME1 in Ogataea polymorpha
por: Yamamoto, Katsuyoshi, et al.
Publicado: (2017)

Effectiveness of taxanes following nivolumab in patients with advanced esophageal squamous cell carcinoma: a retrospective chart review of patients in ATTRACTION-3
por: Chin, Keisho, et al.
Publicado: (2022)

Late-onset isolated adrenocorticotropic hormone deficiency caused by nivolumab: a case report
por: Takeno, Ayumu, et al.
Publicado: (2019)

Esophageal cancer responsive to the combination of immune cell therapy and low-dose nivolumab: two case reports
por: Takimoto, Rishu, et al.
Publicado: (2021)

Efficacy and safety of nivolumab for advanced gastric cancer patients with poor performance statuses
por: Matsumoto, Toshihiko, et al.
Publicado: (2020)

Immune-related Colitis Induced by the Long-term Use of Nivolumab in a Patient with Non-small Cell Lung Cancer
por: Yasuda, Yuichiro, et al.
Publicado: (2017)

Eosinophilic Cholangitis Without Biliary Stricture After the Treatment of Eosinophilic Esophagitis
por: Tanaka, Shunta, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vm6tutdvjdubbkpas8hia8ioo3